Literature DB >> 18028395

Physicians' perceptions of adherence to prophylactic clotting factor infusions.

C D Thornburg1.   

Abstract

The objective of this study was to investigate whether paediatric Haemophilia Treatment Centre (HTC) physicians are concerned about poor adherence to prophylaxis and if such concerns decrease prescription of prophylaxis in patients with haemophilia. Fifty-nine HTC physicians completed a written survey based on self-report of individual practice. Fifty-one (86%) prescribed prophylaxis on a routine basis. Overall, 32 (54%) believed that 76-100% of the patients on prophylaxis infuse > or =80% of the recommended prophylaxis doses and 25 (42%) believed that 51-75% of the patients infuse > or =80% of the doses. Physicians utilize multi-modal methods to make this assessment. Forty-eight (81%) respondents identified that perceptions of patient non-adherence decrease their prescription of prophylaxis. In fact, 30% decided not to prescribe prophylaxis for individual patients within the last year secondary to concerns about non-adherence. Strategies should be developed to improve the implementation of prophylaxis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18028395     DOI: 10.1111/j.1365-2516.2007.01591.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  11 in total

1.  HIV providers' perceptions of and attitudes toward female versus male patients.

Authors:  Oni J Blackstock; Mary Catherine Beach; P Todd Korthuis; Jonathan A Cohn; Victoria L Sharp; Richard D Moore; Somnath Saha
Journal:  AIDS Patient Care STDS       Date:  2012-09-14       Impact factor: 5.078

2.  Disparity in physician perception of patients' adherence to medications by obesity status.

Authors:  Mary Margaret Huizinga; Sara N Bleich; Mary Catherine Beach; Jeanne M Clark; Lisa A Cooper
Journal:  Obesity (Silver Spring)       Date:  2010-02-25       Impact factor: 5.002

3.  Prophylaxis therapy in paediatric patients with haemophilia: a survey of clinical management trends in Italy.

Authors:  Giancarlo Castaman; Angiola Rocino; M Gabriella Mazzucconi; Ezio Zanon; Fabio Gagliano; Angelo C Molinari
Journal:  Blood Transfus       Date:  2015-05-14       Impact factor: 3.443

4.  Factors associated with the accuracy of physicians' predictions of patient adherence.

Authors:  L Alison Phillips; Elaine A Leventhal; Howard Leventhal
Journal:  Patient Educ Couns       Date:  2011-04-17

5.  Validation of the VERITAS-Pro treatment adherence scale in a Spanish sample population with hemophilia.

Authors:  Rubén Cuesta-Barriuso; Ana Torres-Ortuño; Pilar Galindo-Piñana; Joaquín Nieto-Munuera; Natalie Duncan; José Antonio López-Pina
Journal:  Patient Prefer Adherence       Date:  2017-03-27       Impact factor: 2.711

6.  Patient preferences in the treatment of hemophilia A: impact of storage conditions on product choice.

Authors:  Bernd Tischer; Renato Marino; Mariasanta Napolitano
Journal:  Patient Prefer Adherence       Date:  2018-03-26       Impact factor: 2.711

Review 7.  Treatment adherence in hemophilia.

Authors:  Courtney D Thornburg; Natalie A Duncan
Journal:  Patient Prefer Adherence       Date:  2017-09-27       Impact factor: 2.711

8.  Validation of the Brazilian version of the VERITAS-Pro scale to assess adherence to prophylactic regimens in hemophilia.

Authors:  Adriana Aparecida Ferreira; Isabel Cristina Gonçalves Leite; Natalie August Duncan
Journal:  Rev Bras Hematol Hemoter       Date:  2017-11-26

9.  Adherence to prophylaxis in adolescents and young adults with severe haemophilia: a qualitative study with healthcare professionals.

Authors:  S van Os; N Ryder; D P Hart; N Troop
Journal:  Health Psychol Behav Med       Date:  2020-01-28

Review 10.  Therapeutic and routine prophylactic properties of rFactor VIII Fc (efraloctocog alfa, Eloctate®) in hemophilia A.

Authors:  Pratima Chowdary; Emma Fosbury; Anne Riddell; Mary Mathias
Journal:  J Blood Med       Date:  2016-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.